|
US2010040552A1
|
|
Methods to evaluate glucocorticoid receptor agonists and antagonists for effects on neuron-like cells
|
|
US2010113287A1
|
|
Methods for assessing the representation of nucleic acid molecules in a nucleic acid library
|
|
WO2009046021A1
|
|
Integrated genomic system
|
|
US2009011488A1
|
|
Methods for storing compositions useful for synthesizing nucleic acid molecules
|
|
EP2173907A1
|
|
Methods for quantitating small rna molecules
|
|
US2008161549A1
|
|
Method of purifying nucleic acid molecules using proteinase k
|
|
WO2008005281A2
|
|
Genes associated with chemotherapy response and uses thereof
|
|
WO2007147067A2
|
|
Methods and compositions for regulating cell cycle progression
|
|
WO2007100986A2
|
|
Extraction and diagnostic fluid devices, systems and methods of use
|
|
WO2007050990A2
|
|
Nucleic acid amplification using non-random primers
|
|
WO2007041453A2
|
|
Methods and compositions for treating cancer
|
|
US2006292623A1
|
|
Signature genes in chronic myelogenous leukemia
|
|
CA2611528A1
|
|
Targets for inhibiting hcv replication
|
|
US2006241869A1
|
|
Computer systems and methods for inferring causality from cellullar constituent abundance data
|
|
EP1848825A2
|
|
Methods of predicting chemotherapy responsiveness in breast cancer patients
|
|
EP1851336A2
|
|
Methods for quantitating small rna molecules
|
|
AU2005267756A1
|
|
Prognosis of breast cancer patients
|
|
US2005272082A1
|
|
Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
|
|
AU2005233627A1
|
|
Methods for identifying genes that mediate a response of a living cell to an agent
|
|
US2005176125A1
|
|
Alternatively spliced isoform of CDC25A phosphatase and methods of use
|
